| |
| |
|
| Insider
Information: |
Mulroy Dennis |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,031 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,566 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,031 |
|
|
| Total
Value |
$54,566 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2020-05-29 |
5,067 |
2018-10-15 |
0 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
|
2024-05-22 |
964 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2023-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
6,964 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Chief Financial Officer |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,245 |
6,209 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-11-29 |
4 |
A |
$2.33 |
$322 |
D/D |
138 |
4,690 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-12-13 |
4 |
A |
$2.85 |
$319 |
D/D |
112 |
4,802 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-12-31 |
4 |
A |
$3.34 |
$53 |
D/D |
16 |
4,818 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-05-29 |
4 |
A |
$4.01 |
$329 |
D/D |
82 |
5,067 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-05-31 |
4 |
A |
$4.58 |
$1,589 |
D/D |
347 |
2,399 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$4.85 |
$315 |
D/D |
65 |
1,165 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-11-15 |
4 |
A |
$5.12 |
$317 |
D/D |
62 |
4,552 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-01-31 |
4 |
A |
$5.13 |
$323 |
D/D |
63 |
1,040 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-02-15 |
4 |
A |
$5.30 |
$318 |
D/D |
60 |
1,100 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-03-29 |
4 |
A |
$5.47 |
$323 |
D/D |
59 |
1,273 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-05-15 |
4 |
A |
$5.58 |
$1,590 |
D/D |
285 |
2,052 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-04-15 |
4 |
A |
$5.61 |
$325 |
D/D |
58 |
4,876 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-01-15 |
4 |
A |
$5.74 |
$1,814 |
D/D |
316 |
977 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-05-15 |
4 |
A |
$5.86 |
$328 |
D/D |
56 |
4,985 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-10-31 |
4 |
A |
$5.96 |
$1,591 |
D/D |
267 |
4,490 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-04-15 |
4 |
A |
$6.09 |
$1,589 |
D/D |
261 |
1,534 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-04-30 |
4 |
A |
$6.17 |
$327 |
D/D |
53 |
4,929 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-03-15 |
4 |
A |
$6.49 |
$318 |
D/D |
49 |
1,214 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-04-30 |
4 |
A |
$6.84 |
$1,594 |
D/D |
233 |
1,767 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-07-31 |
4 |
A |
$7.11 |
$1,593 |
D/D |
224 |
3,221 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-10-15 |
4 |
A |
$7.12 |
$1,595 |
D/D |
224 |
4,223 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-09-30 |
4 |
A |
$7.48 |
$1,593 |
D/D |
213 |
3,999 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2019-07-15 |
4 |
A |
$7.85 |
$1,594 |
D/D |
203 |
2,997 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
